The Alzheimer’s Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer’s and Parkinson’s

The collaboration will accelerate scalable, minimally invasive biomarkers, continuing momentum toward precision medicine NEW YORK, July 13, 2026 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) today…

Source: prnewswire

Country: United States